These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9469984)

  • 1. [Prevalence of hidradenitis suppurativa in Denmark].
    Jemec GB; Heidenheim M; Nielsen NH
    Ugeskr Laeger; 1998 Feb; 160(6):847-9. PubMed ID: 9469984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of hidradenitis suppurativa and its potential precursor lesions.
    Jemec GB; Heidenheim M; Nielsen NH
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):191-4. PubMed ID: 8708018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.
    Revuz JE; Canoui-Poitrine F; Wolkenstein P; Viallette C; Gabison G; Pouget F; Poli F; Faye O; Roujeau JC; Bonnelye G; Grob JJ; Bastuji-Garin S
    J Am Acad Dermatol; 2008 Oct; 59(4):596-601. PubMed ID: 18674845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.
    Esmann S; Dufour DN; Jemec GB
    Br J Dermatol; 2010 Jul; 163(1):102-6. PubMed ID: 20331444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa.
    Vinding GR; Miller IM; Zarchi K; Ibler KS; Ellervik C; Jemec GB
    Br J Dermatol; 2014 Apr; 170(4):884-9. PubMed ID: 24329520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases.
    Wolkenstein P; Loundou A; Barrau K; Auquier P; Revuz J;
    J Am Acad Dermatol; 2007 Apr; 56(4):621-3. PubMed ID: 17097366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Squamous cell carcinoma as a rare complication of hidradenitis suppurativa].
    Vogelaar FJ; Willems JM
    Ned Tijdschr Geneeskd; 2010; 154():A1137. PubMed ID: 20456772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidradenitis suppurativa--characteristics and consequences.
    Jemec GB; Heidenheim M; Nielsen NH
    Clin Exp Dermatol; 1996 Nov; 21(6):419-23. PubMed ID: 9167336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of body weight on the prevalence and severity of hidradenitis suppurativa.
    Kromann CB; Ibler KS; Kristiansen VB; Jemec GB
    Acta Derm Venereol; 2014 Sep; 94(5):553-7. PubMed ID: 24577555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa: importance of early treatment; efficient treatment with electrosurgery.
    Aksakal AB; Adişen E
    Dermatol Surg; 2008 Feb; 34(2):228-31. PubMed ID: 18093196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity.
    Schrader AM; Deckers IE; van der Zee HH; Boer J; Prens EP
    J Am Acad Dermatol; 2014 Sep; 71(3):460-7. PubMed ID: 24880664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis.
    Bui TL; Silva-Hirschberg C; Torres J; Armstrong AW
    J Am Acad Dermatol; 2018 Feb; 78(2):395-402. PubMed ID: 29056237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotherapy of hidradenitis suppurativa--still valid today?].
    Fröhlich D; Baaske D; Glatzel M
    Strahlenther Onkol; 2000 Jun; 176(6):286-9. PubMed ID: 10897256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hidradenitis suppurativa: number of diagnosed patients, demographic characteristics, and treatment patterns in the United States.
    McMillan K
    Am J Epidemiol; 2014 Jun; 179(12):1477-83. PubMed ID: 24812161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa.
    Giamarellos-Bourboulis EJ; Antonopoulou A; Petropoulou C; Mouktaroudi M; Spyridaki E; Baziaka F; Pelekanou A; Giamarellou H; Stavrianeas NG
    Br J Dermatol; 2007 Jan; 156(1):51-6. PubMed ID: 17199566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR; Bos JD
    Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States.
    Cosmatos I; Matcho A; Weinstein R; Montgomery MO; Stang P
    J Am Acad Dermatol; 2013 Mar; 68(3):412-9. PubMed ID: 22921795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
    Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
    J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
    Shlyankevich J; Chen AJ; Kim GE; Kimball AB
    J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.